Nephrocalcinosis: A potential complication of bisphosphonate therapy in children

Journal of Paediatrics and Child Health

Volumn 47, Issue 12, 2011, Pages 929-930

  Jensen, Diane E ^a,b   McGill, James ^b   Batch, Jennifer ^b  

^a Royal Children's Hospital Foundation   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CALCIUM; COLECALCIFEROL; PAMIDRONIC ACID;

ADOLESCENT; CASE REPORT; CHILD; COMPRESSION FRACTURE; CRUSH TRAUMA; DRUG WITHDRAWAL; FEMALE; FRACTURE; HIP FRACTURE; HUMAN; KIDNEY CALCIFICATION; LETTER; MALE; OSTEOGENESIS IMPERFECTA; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; ULTRASOUND;

ADOLESCENT; BONE DENSITY CONSERVATION AGENTS; CHILD; CHILD, PRESCHOOL; DIPHOSPHONATES; FEMALE; HUMANS; MALE; NEPHROCALCINOSIS; OSTEOGENESIS IMPERFECTA; OSTEOPOROSIS;

EID: 84055218567     PISSN: 10344810     EISSN: 14401754     Source Type: Journal    
DOI: 10.1111/j.1440-1754.2011.02391.x     Document Type: Letter

References (5)

1. Bachrach LK, Ward LM,. Clinical review: bisphosphonate use in childhood osteoporosis. J. Clin. Endocrinol. Metab. 2009; 94: 400-9.
2. Sayer JA, Carr G, Simmons NL,. Nephrocalcinosis: molecular insights into calcium precipitation within the kidney. Clin. Sci. (Lond.) 2004; 106: 549-61. (Pubitemid 38797565)
3. Bereket A, Erdogan T,. Oral bisphosphonate therapy for vitamin D intoxication of the infant. Pediatrics 2003; 111: 899-901. (Pubitemid 36402921)
4. Williams PR, Smith NC, Cooke-Yarborough C, Little DG,. Bisphosphonates and nephrocalcinosis in a rabbit leg lengthening model: a histological and therapeutic comparison. Pharmacol. Toxicol. 2001; 89: 149-52. (Pubitemid 32905246)
5. Atabek ME, Pirgon O, Sert A,. Oral alendronate therapy for severe vitamin D intoxication of the infant with nephrocalcinosis. J. Pediatr. Endocrinol. Metab. 2006; 19: 169-72. (Pubitemid 43337894)